Analyst Price Targets — LFVN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 5, 2026 1:47 pm | Brooks O'Neil | Loop Capital Markets | $5.00 | $4.54 | StreetInsider | Lifevantage Corporation (LFVN) PT Lowered to $5 at Lake Street Capital Markets |
| February 5, 2026 1:45 pm | — | Lake Street | $5.00 | $4.60 | TheFly | LifeVantage price target lowered to $5 from $12 at Lake Street |
| November 5, 2025 2:10 pm | Ryan Meyers | Lake Street | $12.00 | $7.03 | TheFly | LifeVantage price target lowered to $12 from $30 at Lake Street |
| January 14, 2025 12:42 pm | Alex Fuhrman | Craig-Hallum | $35.00 | $16.45 | TheFly | LifeVantage initiated with a Buy at Craig-Hallum |
| January 10, 2025 1:44 pm | Brooks O'Neil | Lake Street | $30.00 | $22.52 | TheFly | LifeVantage price target raised to $30 from $26 at Lake Street |
| December 19, 2024 1:17 pm | Brooks O'Neil | Lake Street | $26.00 | $14.60 | TheFly | LifeVantage initiated with a Buy at Lake Street |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for LFVN

Investors need to pay close attention to LFVN stock based on the movements in the options market lately.

LifeVantage Corporation (LFVN) Q3 2026 Earnings Call Transcript

Lifevantage (LFVN) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.26 per share a year ago.

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid June 15, 2026 to all stockholders of record at the close of…

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2026. Third Quarter Fiscal 2026 Summary*: Revenue was $43.7 million, a decrease of 25.2% from the prior year period; Revenue in the…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LFVN.
U.S. House Trading
No House trades found for LFVN.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
